An Introduction to the Japanese Immunization Program: Past, Present, and Future Perspectives.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
01 05 2023
01 05 2023
Historique:
medline:
14
4
2023
pubmed:
17
2
2023
entrez:
16
2
2023
Statut:
ppublish
Résumé
In Japan, immunization is regulated by the Immunization Law, enacted shortly after World War II ended. It has been subsequently revised in response to social changes; however, after public health conditions improved, adverse events following immunization have received more public attention than the effectiveness of vaccination. This kind of public opinion had a major impact on the immunization program, leading to a so-called "vaccine gap" around a decade ago, that is, the less availability of vaccines for routine vaccination as compared with other countries. However, in recent years, several vaccines have been approved and are being routinely administered with the same schedule as in other countries. National immunization programs are influenced by various factors, such as cultures, customs, habits and ideas. This paper summarizes the status of immunization schedule and practices in Japan, process of policymaking, and possible future issues.
Identifiants
pubmed: 36795581
doi: 10.1097/INF.0000000000003854
pii: 00006454-202305000-00020
doi:
Substances chimiques
Vaccines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e154-e157Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Government of Japan. Immunization Act No. 68 of 1948. (Amendment Act No. 75 of 2020 ) [in Japanese]. 1948. Available at: https://elaws.egov.go.jp/document?lawid=323AC00 00000068&msclkid=54af0d94a93211ec8ff6f73a9b87d507 . Accessed October 7, 2020.
Katsuta T, Moser CA, Feemster KA, et al. Comparison of immunization systems in Japan and the United States – What can be learned? Vaccine. 2020;38:7401–7408.
Ueda K, Miyazaki C, Hidaka Y, et al. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet. 1995;346:701–702.
Kimura M, Kuno-Sakai H, Yamada A, et al. Adverse events associated with MMR vaccines in Japan. Acta Paediatr Jpn. 1996;38:205–211.
Pharmaceutical Research and Manufacturers of America (PhRMA). The value of vaccines. In: The change of the Japanese immunization policy; 2014. Available at: https://www.phrma-jp.org/wordpress/wp-content/uploads/old/library/the_value_of_vaccine/the_value_of_vaccine01.pdf
Nakatani H, Sano T, Iuchi T. Development of vaccination policy in Japan: Current issues and policy directions. Jpn J Infect Dis. 2002;55:101–111.
Saitoh A, Okabe N. Current issues with the immunization program in Japan: can we fill the ‘‘vaccine gap?” Vaccine. 2012;30:4752–4756.
Saitoh A, Okabe N. Progress and challenges for the Japanese immunization program: Beyond the ‘‘vaccine gap.” Vaccine. 2018;36:4582–4588.
Ministry of Health, Labor and Welfare. General Vaccination Action Plan (in Japanese). 2013. Available at: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/ kekkaku-kansenshou/kihonteki_keikaku/index.html . Accessed on October 7, 2022.
Ozaki T, Asano Y. Development of varicella vaccine in Japan and future prospects. Vaccine. 2016;34:3427–3433.
Saitoh A, Okabe N. Changes and remaining challenges for the Japanese immunization program: Closing the vaccine gap. Vaccine. 2021;39:3018–3024.
Yamaguchi T, Iwagami M, Ishiguro C, et al. Safety monitoring of COVID-19 vaccines in Japan. Lancet Reg Health West Pac. 2022;23:100442.
Pharmaceuticals and Medical Devices Agency. Relief system for sufferers from adverse drug reactions Act (Act No. 192 of 2002 ) [in Japanese]. 2002. Available at: https://elaws.e-gov.go.jp/document?lawid=414AC0000000192 . Accessed on October 7, 2020.
Japan Pediatric Society. Immunization Schedule Recommended by the Japan Pediatric Society . 2020 October. Available at: http://www.jpeds.or.jp/uploads/files/ 2020%20English%20JPS%20Immunization%20Schedule.pdf . Accessed on October 26, 2020.
World Health Organization. Immunization Dashboard, Japan. 2021. Available at: https://immunizationdata.who.int/pages/profiles/jpn.html . Accessed on October 7, 2022.
National Institute of Infectious Diseases. Epidemiology of pertussis in Japan under COVID-19 pandemic [in Japanese]. Infectious Agents Surveillance Report. 2021; 42: 113–114. Available at: https://www.niid.go.jp/niid/ja/typhi-m/iasr-reference/2540-related-articles/related-articles-496/10456-496r03.html
Bryson M, Duclos P, Jolly A, et al. A systematic review of national immunization policy making processes. Vaccine. 2010;28:A6–A12.
Ricciardi GW, Toumi M, Weil-Oliver C, et al. Comparison of NITAG policies and working processes in selected developed countries. Vaccine. 2015;33:3–11.